Medically reviewed by Jurairat J. Molina, MD Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria ...
1 Only 19.5% of patients reported they sometimes forget to take their medication ... therapy for both acute and chronic urticaria, some patients need additional treatment to find relief.
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...
Background: Chronic idiopathic urticaria ... Direct cost parameters were medications used, medical procedures and hospitalisations for urticaria or treatment of adverse events.
Celldex Therapeutics, Longbio Pharma, Celltrion, Enanta Pharmaceuticals, Evommune, and others are evaluating new urticaria drugs to improve the treatment landscape. Promising pipeline urticaria ...